PAVmed (PAVM) Short-term Investments (2024 - 2025)

PAVmed (PAVM) recorded quarterly Short-term Investments of $299000.0 in Q3 2025, little changed quarter-over-quarter from $299000.0 in Q2 2025.

PAVmed (PAVM) Short-term Investments (2024 - 2025) Analysis & Trends

PAVmed's Short-term Investments history runs 2 years deep, the most recent figure standing at $299000.0 for Q3 2025.

In Q3 2025, Short-term Investments changed N/A year-over-year to $299000.0; the TTM figure through Sep 2025 stood at $299000.0 (changed N/A YoY), while the FY2024 annual figure was $299000.0, changed N/A from the prior year.
Short-term Investments was $299000.0 for Q3 2025 at PAVmed, roughly flat from $299000.0 in the prior quarter.
In the past five years, Short-term Investments ranged from a high of $299000.0 in Q4 2024 to a low of $299000.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	152.92 Bn	146.27 Bn	6.27 Bn
2	Stryker	119.50 Bn	116.62 Bn	3.81 Bn
3	Medtronic	102.71 Bn	94.54 Bn	5.76 Bn
4	Boston Scientific	69.72 Bn	68.51 Bn	3.61 Bn
5	Edwards Lifesciences	49.24 Bn	45.57 Bn	1.29 Bn
6	GE HealthCare Technologies	29.74 Bn	27.67 Bn	1.98 Bn
7	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
8	Dexcom	28.96 Bn	27.84 Bn	750.30 Mn
9	Steris	20.31 Bn	19.88 Bn	697.10 Mn
10	PAVmed	3.32 Mn	-9.85 Mn	-703,000.00

Download Data